NASDAQ : CLPT
$0.74 (5.53%)
6.48%
41
change: -84.0 | last: 12523
change: -51.0 | last: 747
change: -14.0 | last: 2110
change: -19.0 | last: 2990
change: 63.0 | last: 27-
-
0.00
change: -55.0759 | last: 0.550834.14M
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | MAK Capital Fund LP | 1.9M | 6.30% |
| 2026-04-20 | BIGGER CAPITAL FUND L P | 1.36M | 4.54% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-03-13 | MAK Capital Fund LP | 1.73M | 6.10% |
| 2026-02-04 | BIGGER CAPITAL FUND L P | 1.33M | 4.69% |
| 2025-11-12 | BIGGER CAPITAL FUND L P | 1.29M | 4.55% |
| 2025-08-04 | BIGGER CAPITAL FUND L P | 1.17M | 4.20% |
| 2025-07-29 | The Vanguard Group | 1.48M | 5.27% |
| 2025-07-17 | BlackRock, Inc. | 1.58M | 5.60% |
| 2025-05-09 | BIGGER CAPITAL FUND L P | 1.13M | 4.00% |
| 2025-01-29 | BIGGER CAPITAL FUND L P | 1.11M | 4.00% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 1.31M | 5.32% |
| 2024-01-29 | (1) BlackRock, Inc. | 1.47M | 6.00% |
| 2021-06-09 | Bigger Capital Fund, LP | 575.48K | 2.80% |
| 2021-03-02 | PTC Therapeutics, Inc. | 2.96M | 14.00% |
| 2021-02-11 | Thomas A. Satterfield, Jr. | 720K | 4.00% |
| 2020-02-13 | Thomas A. Satterfield, Jr. | 1.22M | 7.80% |
| 2020-01-31 | PTC Therapeutics, Inc. | 2.96M | 17.27% |
| 2019-05-24 | PTC Therapeutics, Inc. | 1.29M | 9.56% |
| 2018-02-09 | E. Jeffrey Peierls(1) | 690K | 9.99% |
| 2018-02-05 | Mellon Group, LLC | 587.6K | 5.60% |
| 2018-01-12 | Page 1 of 5 | 600K | 5.80% |
| 2017-10-04 | only). | 506.62K | 4.90% |
| 2017-10-04 | only). | 506.62K | 4.90% |
| 2017-09-19 | Page 1 of 5 | 586.86K | 5.70% |
| 2017-07-11 | Sabby Healthcare Master Fund, Ltd. | 756.62K | 4.46% |
| 2017-06-08 | 2. | 800K | 7.70% |
| 2017-06-08 | 2. | 8M | 7.70% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $13.68 | 28.32M | $387.35M | $45.92M | $58.23M | $399.66M |
| 2024-12-31 | $15.38 | 27.03M | $415.69M | $20.1M | $3.57M | $399.15M |
| 2023-12-31 | $6.79 | 24.61M | $167.07M | $23.14M | $13.94M | $157.87M |
| 2022-12-31 | $8.47 | 24.18M | $204.82M | $27.62M | $11.99M | $189.19M |
| 2021-12-31 | $11.22 | 20.73M | $232.64M | $54.11M | $12.28M | $190.81M |
| 2020-12-31 | $15.89 | 15.85M | $251.85M | $20.1M | $24.12M | $255.87M |
| 2019-12-31 | $4.80 | 13.16M | $63.14M | $5.7M | $2.46M | $59.91M |
| 2018-12-31 | $1.57 | 10.93M | $17.16M | $3.1M | $3.48M | $17.54M |
| 2017-12-31 | $2.75 | 7.74M | $21.28M | $9.29M | $4.92M | $16.91M |
| 2016-12-31 | $3.40 | 2.75M | $9.37M | $3.32M | $4.49M | $10.54M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17.84 | 29.86M | $532.68M | $29.36M | $63.95M | $567.26M |
| 2026-03-31 | $9.10 | 29.55M | $268.88M | $35.59M | $63.59M | $296.87M |
| 2025-12-31 | $13.68 | 28.32M | $387.35M | $45.92M | $58.23M | $399.66M |
| 2025-09-30 | $21.79 | 28.43M | $619.44M | $38.22M | $35.74M | $616.96M |
| 2025-06-30 | $11.94 | 28.26M | $337.4M | $41.54M | $35.46M | $331.32M |
| 2025-03-31 | $11.89 | 27.72M | $329.58M | $12.39M | $3.44M | $320.63M |
| 2024-12-31 | $15.38 | 27.03M | $415.69M | $20.1M | $3.57M | $399.15M |
| 2024-09-30 | $11.21 | 27.59M | $309.3M | $21.57M | $3.69M | $291.42M |
| 2024-06-30 | $5.33 | 27.47M | $146.41M | $32.84M | $13.8M | $127.36M |
| 2024-03-31 | $6.73 | 25.45M | $171.29M | $35.35M | $13.9M | $149.84M |
| 2023-12-31 | $6.79 | 24.63M | $167.22M | $23.14M | $13.94M | $158.03M |
| 2023-09-30 | $5.01 | 24.63M | $123.4M | $24.34M | $14.01M | $113.07M |